Etienne Rauber

发表

Discovery of carmegliptin: a potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

Holger Fischer, Bernd Kuhn, B. Kuhn, 2010, Bioorganic & medicinal chemistry letters.